Ampio Pharmaceuticals, Inc.
General ticker "AMPE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $8.8K (TTM average)
Ampio Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 9.5%.
Estimated limits based on current volatility of -1023.2%: low -0.00$, high 0.00$
Factors to consider:
- Total employees count: 3 as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Litigation risks, Market volatility, Potential dissolution or bankruptcy, Strategic risks and growth management
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.98$, 3.44$]
- 2024-12-30 to 2025-12-30 estimated range: [0.68$, 2.43$]
Financial Metrics affecting the AMPE estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -523.76 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 58.58 <= 63.39
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.66
Short-term AMPE quotes
Long-term AMPE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.57MM | $20.38MM | $9.52MM |
| Operating Income | $-20.57MM | $-20.38MM | $-9.52MM |
| Non-Operating Income | $3.50MM | $4.04MM | $0.89MM |
| R&D Expense | $11.90MM | $8.92MM | $2.32MM |
| Income(Loss) | $-17.07MM | $-16.34MM | $-8.63MM |
| Taxes | $-4.59MM | $-7.87MM | $0.00MM |
| Profit(Loss)* | $-12.48MM | $-16.34MM | $-8.63MM |
| Stockholders Equity | $27.28MM | $11.79MM | $3.36MM |
| Inventory | $0.07MM | $0.00MM | $0.00MM |
| Assets | $38.83MM | $13.59MM | $5.74MM |
| Operating Cash Flow | $-14.09MM | $-21.13MM | $-8.56MM |
| Capital expenditure | $0.10MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.10MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $30.73MM | $-0.11MM | $0.00MM |
| Earnings Per Share** | $-18.79 | $-29.33 | $-10.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.